Palatin Technologies Inc Key Opinion Leader Webinar Transcript
Good morning, and thank you for joining us for the Palatin KOL Webinar. (Operator Instructions) As a reminder, this conference is being recorded, and a replay will be made available on the Palatin website following the conclusion of the event.
I would now like to turn the call over to your host, Carl Spana, President and Chief Executive Officer of Palatin. Please go ahead, Carl.
Thank you, Sara. Steve and I would like to welcome all of the attendees that are listening into the Palatin seminar today on melanocortin agonist for ocular diseases. Today, we have actually a very full agenda for you with a number of very distinguished guest speakers, which we'll introduce in a second. You're going to hear a lot today about the melanocortin system and its role in resolving inflammation and in particular, how we're applying it to development of therapeutics for ocular indications.
Just as a housekeeping point, questions will be at the end after all of the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |